Back

The association of lipoprotein(a) with patient characteristics and mortality in a primary prevention cohort: data from our clinic database

27 August 2023 (10:15 - 10:45)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment: biomarkers Biomarkers ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Leslie Cho

Cleveland Clinic, Cleveland (United States of America)

3 More presentations in this session

Presentation thumbnail
Plasma proteomics identify fibroblast growth factor 5 as a biomarker for genetically proven Familial Hypercholesterolemia
Doctor A. Baragetti (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Plasma levels of amyloid beta 1-40 are associated with ultrasonographic morphological characteristics related with carotid plaque vulnerability in individuals without cardiovascular disease
Doctor D. Delialis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Association of random glucose to albumin ratio with post-contrast acute kidney injury and clinical outcomes in patients with ST-elevation myocardial infarction
Mr Y. Liu (Guangzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk assessment: biomarkers

The Event

Event poster

ESC Congress 2023

27 August 2023 10:15 CET
You may be interested in
thumbnail
Congress Presentation
A sex-related analysis on the influence of lipoprotein(a) on primary cardiovascular disease prevention and its interplay with traditional lipid markers: results from a 20-year cohort study.
thumbnail
Congress Presentation
The distribution of lipoprotein(a) in Norway: a nationwide population-based study
thumbnail
Congress Presentation
Hyperlipoproteinemia(a) in coronary artery disease patients: who are patients with very high levels and how do they respond to the PCSK9 antibody therapy?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources